Skip to main content
Addgene

pLVX-CLK1
(Plasmid #174088)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 174088 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pLVX
  • Backbone manufacturer
    Clonetech
  • Backbone size w/o insert (bp) 7756
  • Total vector size (bp) 9269
  • Vector type
    Mammalian Expression, Lentiviral
  • Selectable markers
    Puromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    CLK1
  • Alt name
    Dual Specificity Protein Kinase CLK1
  • Alt name
    CDC Like Kinase 1
  • Alt name
    Protein Tyrosine Kinase STY
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    1452
  • GenBank ID
    1195
  • Entrez Gene
    CLK1 (a.k.a. CLK, CLK/STY, STY)
  • Promoter TREtight
  • Tag / Fusion Protein
    • Myc-GSSS (N terminal on insert)

Cloning Information

  • Cloning method Gibson Cloning
  • 5′ sequencing primer gtcgaggtaggcgtgtacgg
  • 3′ sequencing primer gaggccagaggccacttgtgtag
  • (Common Sequencing Primers)

Resource Information

  • Supplemental Documents
  • A portion of this plasmid was derived from a plasmid made by
    DNASU: HsCD00038192

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pLVX-CLK1 was a gift from Wesley Sundquist & Katie Ullman (Addgene plasmid # 174088 ; http://n2t.net/addgene:174088 ; RRID:Addgene_174088)
  • For your References section:

    Identification of abscission checkpoint bodies as structures that regulate ESCRT factors to control abscission timing. Williams LK, Mackay DR, Whitney MA, Couldwell GC, Sundquist WI, Ullman KS. Elife. 2021 Aug 4;10. pii: 63743. doi: 10.7554/eLife.63743. 10.7554/eLife.63743 PubMed 34346309